ValiRx plc (LON:VAL – Get Free Report) was down 10% during trading on Wednesday. The company traded as low as GBX 0.15 and last traded at GBX 0.15. Approximately 36,266,617 shares were traded during trading, an increase of 172% from the average daily volume of 13,324,604 shares. The stock had previously closed at GBX 0.17.
ValiRx Trading Down 10.0%
The company has a market capitalization of £2.02 million, a PE ratio of -0.37 and a beta of 0.59. The stock’s fifty day moving average is GBX 0.14 and its two-hundred day moving average is GBX 0.22.
ValiRx (LON:VAL – Get Free Report) last released its earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. As a group, analysts anticipate that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
- Why Apple Stock Looks Like a Safe Haven After the Midterms
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
-tbk-logo-1200x675.png){kind=logo}